Therefore, in an attempt to obtain resectable tumor tissues before regression and gain mechanistic insights into the PRG4 and regorafenib synergy, a replicate experiment was conducted with animals being sacrificed at day 12 when tumor size became significant (p < 0.05) (Fig. 2A-E). This evidence concerns the gene PRG4 and neoplasm.